Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
97.986,20
-0,70%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Neuronetics Inc (STIM) Neuronetics Inc (STIM) Notizie

STIM

Neuronetics (STIM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:STIM
DataOraFonteTitoloSimboloCompagnia
19/12/202423:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
18/12/202422:30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
18/12/202403:15Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:STIMNeuronetics Inc
12/12/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
10/12/202422:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
10/12/202416:00GlobeNewswire Inc.Neuronetics and Greenbrook TMS Announce Closing of TransactionNASDAQ:STIMNeuronetics Inc
20/11/202414:30GlobeNewswire Inc.Neuronetics to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:STIMNeuronetics Inc
14/11/202420:32Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:STIMNeuronetics Inc
14/11/202417:32Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:STIMNeuronetics Inc
14/11/202417:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:STIMNeuronetics Inc
13/11/202412:44Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:STIMNeuronetics Inc
13/11/202400:45GlobeNewswire Inc.CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
12/11/202413:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
12/11/202413:10GlobeNewswire Inc.Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
01/11/202422:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:STIMNeuronetics Inc
29/10/202421:30GlobeNewswire Inc.Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
14/10/202414:31GlobeNewswire Inc.NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
08/10/202421:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
04/10/202414:33PR Newswire (US)Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder MeetingsNASDAQ:STIMNeuronetics Inc
04/10/202413:34Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:STIMNeuronetics Inc
25/09/202414:31GlobeNewswire Inc.Health Care Service Corporation Adds First-Line TMS Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
19/09/202414:31GlobeNewswire Inc.Expanded Health Policies Enhance TMS Therapy Access for Adolescents and AdultsNASDAQ:STIMNeuronetics Inc
17/09/202413:32Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:STIMNeuronetics Inc
16/09/202414:32GlobeNewswire Inc.NeuroStar® Releases Software Upgrades to Elevate Patient CareNASDAQ:STIMNeuronetics Inc
03/09/202414:29GlobeNewswire Inc.NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful StoriesNASDAQ:STIMNeuronetics Inc
20/08/202414:29GlobeNewswire Inc.NeuroStar® Marks Two Years of Transformative Impact with NeuroStar UniversityNASDAQ:STIMNeuronetics Inc
12/08/202413:15GlobeNewswire Inc.Neuronetics and Greenbrook TMS Announce Definitive Agreement to MergeNASDAQ:STIMNeuronetics Inc
12/08/202413:10GlobeNewswire Inc.Neuronetics Reports Record Second Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
01/08/202414:29GlobeNewswire Inc.NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health MonthNASDAQ:STIMNeuronetics Inc
31/07/202414:30GlobeNewswire Inc.Neuronetics to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:STIMNeuronetics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:STIM

La tua Cronologia

LSE
QI53
Morg.st.b.v 26
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network